These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3914805)

  • 1. The influence of strict control on diabetic complications.
    Hanssen KF; Dahl-Jørgensen K; Brinchmann-Hansen O
    Acta Endocrinol Suppl (Copenh); 1985; 272():57-60. PubMed ID: 3914805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.
    Lancet; 1982 Jan; 1(8264):121-4. PubMed ID: 6119509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is tight blood sugar control effective and justified? Affirmative.
    Skyler JS
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():17-20; discussion 24-5. PubMed ID: 1347534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight glycemic control? Negative.
    Raskin P
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():21-4; discussion 24-5. PubMed ID: 1347535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-normoglycemia and late diabetic complications. The Oslo Study.
    Dahl-Jørgensen K
    Acta Endocrinol Suppl (Copenh); 1987; 284():1-38. PubMed ID: 3300128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Diabetes Control and Complications Trial: new challenges for the primary physician.
    Clarke WL
    Va Med Q; 1994; 121(3):185-8. PubMed ID: 8061070
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of blood glucose control and retinopathy during long-term treatment of insulin-dependent diabetes mellitus with intraperitoneal infusion of insulin].
    Jaffiol C; Jacques-Apostol D; Renard E; Millet P; Compeyre S; Lauton D; Picot MC; Bringer J
    Bull Acad Natl Med; 1996 Jan; 180(1):177-91; discussion 191-4. PubMed ID: 8696875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic renal-retinal syndrome: does tight control help?
    Cowan CL
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
    [No Abstract]   [Full Text] [Related]  

  • 11. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
    Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy.
    Bangstad HJ; Osterby R; Dahl-Jørgensen K; Berg KJ; Hartmann A; Hanssen KF
    Diabetologia; 1994 May; 37(5):483-90. PubMed ID: 8056186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.
    Beck-Nielsen H; Olesen T; Mogensen CE; Richelsen B; Olsen HW; Ehlers N; Charles P; Sørensen NS
    Diabetes Res; 1990 Dec; 15(4):185-90. PubMed ID: 2132407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment.
    Testa MA; Puklin JE; Sherwin RS; Simonson DC
    Diabetes; 1985 Aug; 34 Suppl 3():61-8. PubMed ID: 3894129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).
    Olsen T; Richelsen B; Ehlers N; Beck-Nielsen H
    Acta Ophthalmol (Copenh); 1987 Apr; 65(2):185-9. PubMed ID: 3300140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intensive treatment on diabetic retinopathy].
    Hanssen KF; Brinchmann-Hansen O; Dahl-Jørgensen K; Sandvik L
    Journ Annu Diabetol Hotel Dieu; 1988; ():167-73. PubMed ID: 3050220
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study.
    Christensen CK; Christiansen JS; Schmitz A; Christensen T; Hermansen K; Mogensen CE
    J Diabet Complications; 1987; 1(3):91-5. PubMed ID: 2969912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.
    Feldt-Rasmussen B; Mathiesen ER; Deckert T
    Lancet; 1986 Dec; 2(8519):1300-4. PubMed ID: 2878175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.